Selected article for: "long term control and lung function"

Author: Qiu, Yingshan; Lam, Jenny K. W.; Leung, Susan W. S.; Liang, Wanling
Title: Delivery of RNAi Therapeutics to the Airways—From Bench to Bedside
  • Document date: 2016_9_20
  • ID: 04pp3lv0_60
    Snippet: COPD is a persistent lung disease characterized by irreversible chronic airflow limitation. The disease is usually progressive and associated with an increased chronic inflammatory response in the lungs [205, 206] . It is the result of long term exposure to air pollutants and usually associated with cigarette smoking [205] . It affects around 10% of the population in the world. It is the fourth leading cause of death in most of the industrialized.....
    Document: COPD is a persistent lung disease characterized by irreversible chronic airflow limitation. The disease is usually progressive and associated with an increased chronic inflammatory response in the lungs [205, 206] . It is the result of long term exposure to air pollutants and usually associated with cigarette smoking [205] . It affects around 10% of the population in the world. It is the fourth leading cause of death in most of the industrialized countries and expected to become the third by 2020 [207] . Three classes of medications used to manage COPD are bronchodilators (including β 2 -adrenergic receptor and anticholinergic drugs), corticosteroids and phosphodiesterase-4 inhibitor. They are effective in relieving the symptoms of COPD, but none of them can reverse the progressive deterioration in lung function or cure the disease [4, 205] . It is desirable to develop a novel therapy that can simultaneously control the symptoms and improve the long-term prognosis of the disease.

    Search related documents:
    Co phrase search for related documents
    • air pollutant and long air pollutant term exposure: 1, 2, 3, 4
    • air pollutant and long term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
    • air pollutant and lung disease: 1
    • air pollutant and lung function: 1
    • air pollutant and term exposure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • air pollutant and world population: 1
    • air pollutant term exposure and long air pollutant term exposure: 1, 2, 3
    • air pollutant term exposure and long term: 1, 2, 3
    • air pollutant term exposure and term exposure: 1, 2, 3, 4
    • airflow limitation and chronic airflow limitation: 1, 2, 3, 4, 5, 6, 7, 8
    • airflow limitation and chronic lung inflammatory response: 1
    • airflow limitation and cigarette smoking: 1, 2, 3
    • airflow limitation and COPD symptom: 1, 2
    • airflow limitation and death leading cause: 1, 2, 3
    • airflow limitation and fourth death leading cause: 1
    • airflow limitation and inflammatory response: 1, 2, 3, 4, 5, 6, 7
    • airflow limitation and leading cause: 1, 2, 3, 4
    • airflow limitation and long term: 1
    • airflow limitation and long term prognosis: 1